Overview
Masaei Onuma practices in Japan. Onuma is rated as an Experienced expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. Their top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Histiocytosis, Reticulohistiocytoma, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.
Their clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Acquired Amegakaryocytic Thrombocytopenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acquired Amegakaryocytic Thrombocytopenia
- Bone Marrow TransplantOnuma isExperienced. Learn about Bone Marrow Transplant.
- FibrosarcomaOnuma isExperienced. Learn about Fibrosarcoma.
- Graft Versus Host Disease (GvHD)
- HistiocytosisOnuma isExperienced. Learn about Histiocytosis.
- Langerhans Cell HistiocytosisOnuma isExperienced. Learn about Langerhans Cell Histiocytosis.